Back
GT Biopharma 10K Form
Buy
55
GTBP
GT Biopharma
Last Price:
2.95
Seasonality Move:
-2.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTBP News And Ratings
See the #1 stock for the next 7 days that we like better than GTBP
GTBP Financial Statistics
Sales & Book Value
| Annual Sales: | $27K |
|---|---|
| Cash Flow: | $-3.54M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.46 |
| Price / Book: | 1.21 |
Profitability
| EPS (TTM): | -7.59360 |
|---|---|
| Net Income (TTM): | $-11.35M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
GT Biopharma Earnings Forecast
Key GT Biopharma Financial Ratios
- The Selling, General & Administrative Expenses for GTBP have been equal to 29,459.26% of Gross Profit Margin.
- The Interest Expense is -2.80% of Operating Income.
- Per Share Earnings over the last 40 years have been positive in 20 years.
GT Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GTBP |
| Website: | gtbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GTBP Technical Analysis vs Fundamental Analysis
Buy
55
GT Biopharma (GTBP)
is a Buy
Is GT Biopharma a Buy or a Sell?
-
GT Biopharma stock is rated a Buy
The current GT Biopharma [GTBP] share price is $2.97. The Score for GTBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.